VAXART INC (VXRT) Stock Fundamental Analysis

NASDAQ:VXRT • US92243A2006

0.32 USD
-0.11 (-25.06%)
At close: Jul 7, 2025
0.3251 USD
+0.01 (+1.59%)
After Hours: 7/7/2025, 10:34:23 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to VXRT. VXRT was compared to 520 industry peers in the Biotechnology industry. VXRT has a bad profitability rating. Also its financial health evaluation is rather negative. VXRT is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year VXRT has reported negative net income.
  • In the past year VXRT has reported a negative cash flow from operations.
  • VXRT had negative earnings in each of the past 5 years.
  • VXRT had a negative operating cash flow in each of the past 5 years.
VXRT Yearly Net Income VS EBIT VS OCF VS FCFVXRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

  • VXRT has a Return On Assets of -36.66%. This is comparable to the rest of the industry: VXRT outperforms 59.32% of its industry peers.
  • With a Return On Equity value of -127.41%, VXRT perfoms like the industry average, outperforming 41.04% of the companies in the same industry.
Industry RankSector Rank
ROA -36.66%
ROE -127.41%
ROIC N/A
ROA(3y)-66.71%
ROA(5y)-50.62%
ROE(3y)-117.91%
ROE(5y)-83.49%
ROIC(3y)N/A
ROIC(5y)N/A
VXRT Yearly ROA, ROE, ROICVXRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

  • VXRT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VXRT Yearly Profit, Operating, Gross MarginsVXRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K -80K -100K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • VXRT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • VXRT has more shares outstanding than it did 1 year ago.
  • VXRT has more shares outstanding than it did 5 years ago.
  • VXRT has a better debt/assets ratio than last year.
VXRT Yearly Shares OutstandingVXRT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
VXRT Yearly Total Debt VS Total AssetsVXRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • Based on the Altman-Z score of -5.12, we must say that VXRT is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -5.12, VXRT is not doing good in the industry: 60.04% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 0.01 indicates that VXRT is not too dependend on debt financing.
  • VXRT's Debt to Equity ratio of 0.01 is in line compared to the rest of the industry. VXRT outperforms 42.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -5.12
ROIC/WACCN/A
WACC9.59%
VXRT Yearly LT Debt VS Equity VS FCFVXRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M 150M

2.3 Liquidity

  • A Current Ratio of 0.64 indicates that VXRT may have some problems paying its short term obligations.
  • VXRT has a worse Current ratio (0.64) than 91.22% of its industry peers.
  • A Quick Ratio of 0.64 indicates that VXRT may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.64, VXRT is doing worse than 90.68% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.64
Quick Ratio 0.64
VXRT Yearly Current Assets VS Current LiabilitesVXRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • VXRT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 49.06%, which is quite impressive.
  • Looking at the last year, VXRT shows a very strong growth in Revenue. The Revenue has grown by 433.37%.
  • Measured over the past years, VXRT shows a very strong growth in Revenue. The Revenue has been growing by 23.72% on average per year.
EPS 1Y (TTM)49.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)433.37%
Revenue growth 3Y217.11%
Revenue growth 5Y23.72%
Sales Q2Q%857.18%

3.2 Future

  • Based on estimates for the next years, VXRT will show a small growth in Earnings Per Share. The EPS will grow by 0.50% on average per year.
  • The Revenue is expected to grow by 30.95% on average over the next years. This is a very strong growth
EPS Next Y15.8%
EPS Next 2Y-6.58%
EPS Next 3Y-9.17%
EPS Next 5Y0.5%
Revenue Next Year-37.03%
Revenue Next 2Y-48.87%
Revenue Next 3Y-34.32%
Revenue Next 5Y30.95%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
VXRT Yearly Revenue VS EstimatesVXRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M 150M 200M 250M
VXRT Yearly EPS VS EstimatesVXRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -0.5 -1 -1.5 -2

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for VXRT. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VXRT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VXRT Price Earnings VS Forward Price EarningsVXRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VXRT Per share dataVXRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 -0.2 -0.3

4.3 Compensation for Growth

  • A cheap valuation may be justified as VXRT's earnings are expected to decrease with -9.17% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.58%
EPS Next 3Y-9.17%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • VXRT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

VAXART INC

NASDAQ:VXRT (7/7/2025, 10:34:23 PM)

After market: 0.3251 +0.01 (+1.59%)

0.32

-0.11 (-25.06%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)05-13
Earnings (Next)08-07
Inst Owners12.07%
Inst Owner Change-14.69%
Ins Owners1.03%
Ins Owner Change1.61%
Market Cap73.03M
Revenue(TTM)47.40M
Net Income(TTM)-58.12M
Analysts86.67
Price Target3.06 (856.25%)
Short Float %1.63%
Short Ratio0.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)41.06%
Min EPS beat(2)31.15%
Max EPS beat(2)50.98%
EPS beat(4)3
Avg EPS beat(4)-26.88%
Min EPS beat(4)-230.84%
Max EPS beat(4)50.98%
EPS beat(8)7
Avg EPS beat(8)-4.36%
EPS beat(12)10
Avg EPS beat(12)-1.05%
EPS beat(16)13
Avg EPS beat(16)-0.9%
Revenue beat(2)1
Avg Revenue beat(2)43%
Min Revenue beat(2)-28.31%
Max Revenue beat(2)114.31%
Revenue beat(4)3
Avg Revenue beat(4)1682.62%
Min Revenue beat(4)-28.31%
Max Revenue beat(4)6175.49%
Revenue beat(8)7
Avg Revenue beat(8)1313.72%
Revenue beat(12)7
Avg Revenue beat(12)849.62%
Revenue beat(16)7
Avg Revenue beat(16)625.02%
PT rev (1m)-35.71%
PT rev (3m)-35.71%
EPS NQ rev (1m)0%
EPS NQ rev (3m)8.83%
EPS NY rev (1m)0%
EPS NY rev (3m)9.95%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)-82.09%
Revenue NY rev (1m)38.91%
Revenue NY rev (3m)323.53%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.54
P/FCF N/A
P/OCF N/A
P/B 1.6
P/tB 1.94
EV/EBITDA N/A
EPS(TTM)-0.27
EYN/A
EPS(NY)-0.39
Fwd EYN/A
FCF(TTM)-0.15
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS0.21
BVpS0.2
TBVpS0.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -36.66%
ROE -127.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-66.71%
ROA(5y)-50.62%
ROE(3y)-117.91%
ROE(5y)-83.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6.2%
Cap/Sales 1.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.64
Quick Ratio 0.64
Altman-Z -5.12
F-Score5
WACC9.59%
ROIC/WACCN/A
Cap/Depr(3y)64.4%
Cap/Depr(5y)72.15%
Cap/Sales(3y)3209.1%
Cap/Sales(5y)2046.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y15.8%
EPS Next 2Y-6.58%
EPS Next 3Y-9.17%
EPS Next 5Y0.5%
Revenue 1Y (TTM)433.37%
Revenue growth 3Y217.11%
Revenue growth 5Y23.72%
Sales Q2Q%857.18%
Revenue Next Year-37.03%
Revenue Next 2Y-48.87%
Revenue Next 3Y-34.32%
Revenue Next 5Y30.95%
EBIT growth 1Y30.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y67.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y64.76%
OCF growth 3YN/A
OCF growth 5YN/A

VAXART INC / VXRT FAQ

Can you provide the ChartMill fundamental rating for VAXART INC?

ChartMill assigns a fundamental rating of 2 / 10 to VXRT.


What is the valuation status for VXRT stock?

ChartMill assigns a valuation rating of 0 / 10 to VAXART INC (VXRT). This can be considered as Overvalued.


What is the profitability of VXRT stock?

VAXART INC (VXRT) has a profitability rating of 1 / 10.


How financially healthy is VAXART INC?

The financial health rating of VAXART INC (VXRT) is 1 / 10.


Can you provide the expected EPS growth for VXRT stock?

The Earnings per Share (EPS) of VAXART INC (VXRT) is expected to grow by 15.8% in the next year.